Play all audios:
ABOUT CIPLA Cipla Ltd., incorporated in the year 1935, is a Large Cap company (having a market cap of Rs 1,18,598.57 Crore) operating in Pharmaceuticals sector. Cipla Ltd. key
Products/Revenue Segments include Pharmaceuticals, Royalty Income, Other Operating Revenue, Export Incentives and Scrap for the year ending 31-Mar-2023. SHAREHOLDINGS: As of 31st Mar, 2025,
the promoter held 29.2% of the stake in Cipla shares, out of which 0.0% was pledged. On the same date, foreign institutional investors' (FII) holdings of Cipla stocks was 26.28% as
compared to 26.65% in Dec 2024 with decrease of 0.37%. The domestic institutional investors (DII) holdings on 31st Mar, 2025 was 27.68% as compared to 27.22% in Dec 2024 with increase of
0.46%. Out of the total DII holdings in Cipla shares 20.51% was held by mutual funds. The rest including public held is 16.84%. Cipla stock price is reflected on both the exchanges - BSE and
NSE. DIVIDEND, BONUS & SPLIT INFORMATION: Cipla Dividend: Ever since 1935, Cipla dividends has been paid out around 32 times. As on 23 May, 2025, 03:58 PM IST, The overall dividend
yield for Cipla stands at 1.29%. The last dividend paid was on June 27, 2025 (Rs. 3.0). The Earnings Per Share (EPS) for quarter ending 31st Mar 2025 is Rs. 65.28. Cipla Bonus: The most
recent bonus issue had been in year April 24, 2006 around 19 years ago at 2 : 3 ratio. The first bonus issue was announced in Aug 1980. STOCK FORECAST: After showing 7151.12 Cr. of sales and
0.22% of quarterly net profit, there have been multiple ups and downs in the Cipla stock prices in the past few weeks. For example, Cipla stock price on 15th of May 2025 was around Rs.
1502.2. Cipla share price now stands at an average of Rs. 1484.20. Judging by last week's performance, stock is in down trend. Cipla has a median target price of Rs. 1651.94 in 12
months by 34 analysts. They have provided a high estimate of Rs. 1875.0 and low estimate of Rs. 1280.0 for Cipla share. HISTORICAL PRICES AND PERFORMANCE: Cipla, incorporated in 1935 is a
Large Cap company (with a market cap of Rs. 118598.57) operating in Pharmaceuticals sector. The Return of Equity (ROE) in last five financial years given by Cipla stock was 16.9%, 15.43%,
11.96%, 12.07% and 13.12% respectively. The Cipla share gave a 3 year return of 50.09% as compared to Nifty 50 which gave a return of 51.29%. Cipla announced 150.0% final dividend on June
27, 2025. KEY METRICS: PE Ratio of Cipla is 22.49 Prices/Sales Ratio of Cipla is 4.23 Price/Book Ratio of Cipla is 3.79 PEER INSIGHTS: Peers are businesses with comparable activities,
buisness objectives and affiliation with a particular industry area. For Cipla, major competitors and peers include Divis Labs, Torrent Pharma, Dr. Reddys and Mankind Pharma. As of Dec 2024,
the dividend yield of Cipla stands at 1.29% while Divis Labs, Torrent Pharma, Dr. Reddys and Mankind Pharma stand at 0.46%, 0.0%, 0.65% and 0.0% respectively. The PE ratio and PB Ratio of
the company are among its competitors stand at 22.49 and 3.79 respectively. RECOMMENDATIONS: The current total number of analysts covering the stock stands at 33, Three months ago this
number stood at 33. Out of total, 7 analyst have a'Strong Buy' reco, 12 analyst have a'Buy' reco, 8 analyst have a'Hold' reco, 6 analyst have a'Sell'
reco. Mean recommendations by 33 analyst stand at'Buy'. LEADERSHIP OF CIPLA : Rajendra Chopra is Co. Secretary & Compl. Officer Ashish Adukia is Global Chief Financial Officer
Raju Mistry is Global Chief People Officer Vijayasarathi Ramaswami is Global Head Sneha Hiranandani is Chief Information Officer Sai Mungara is Global Head Y K Hamied is Chairman M K Hamied
is Vice Chairman Umang Vohra is Managing Director & Global CEO Samina Hamied is Non Exe.Non Ind.Director S Radhakrishnan is Non Exe.Non Ind.Director Ashok Sinha is Independent Director P
R Ramesh is Independent Director Robert Stewart is Independent Director Mandar Vaidya is Independent Director Adil Zainulbhai is Independent Director Punita Lal is Independent Director
Balram Bhargava is Independent Director Show More __ * EXECUTIVES * AUDITORS * YK Y K Hamied Chairman MK M K Hamied Vice Chairman UV Umang Vohra Managing Director & Global CEO SR S
Radhakrishnan Non Exe.Non Ind.Director SH Samina Hamied Non Exe.Non Ind.Director AZ Adil Zainulbhai Independent Director Show More __ * Walker Chandiok & Co. LLP Key Indices Listed on
Nifty 50, Nifty 100, Nifty 200, + 46 more Address Cipla House,Peninsula Business Park,Ganpatrao Kadam Marg,Mumbai, Maharashtra - 400013 MORE DETAILS BRANDS Cipla